Skip to main content

Express Pharma (Vol. 18, No. 3) February 2023

Page 1

VOL. 18 NO. 3 PAGES 68

www.expresspharma.in

MARKET

Most pharma manufacturers/brands and associations downplay actual counterfeiting data: ASPA and Crisil Report

RESEARCH

Advancement of immuno-oncology in India

FEBRUARY 2023, ` 40

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: and more. Sign up and create your flipbook.
Express Pharma (Vol. 18, No. 3) February 2023 by Indian Express - Issuu